Taiwan · Delayed Price · Currency is TWD BioGend Therapeutics Statistics
Total Valuation
TPEX:6733 has a market cap or net worth of TWD 3.52 billion. The enterprise value is 2.68 billion.
| Market Cap | 3.52B |
| Enterprise Value | 2.68B |
Important Dates
The next estimated earnings date is Friday, August 7, 2026.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6733 has 124.36 million shares outstanding. The number of shares has increased by 0.80% in one year.
| Current Share Class | 124.36M |
| Shares Outstanding | 124.36M |
| Shares Change (YoY) | +0.80% |
| Shares Change (QoQ) | +1.04% |
| Owned by Insiders (%) | 4.28% |
| Owned by Institutions (%) | 2.56% |
| Float | 67.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.31 |
| PB Ratio | 3.19 |
| P/TBV Ratio | 3.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -39.89 |
| EV / Sales | 11.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -57.42 |
Financial Position
The company has a current ratio of 34.37, with a Debt / Equity ratio of 0.01.
| Current Ratio | 34.37 |
| Quick Ratio | 32.26 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.12 |
| Interest Coverage | -626.79 |
Financial Efficiency
Return on equity (ROE) is -7.99% and return on invested capital (ROIC) is -5.81%.
| Return on Equity (ROE) | -7.99% |
| Return on Assets (ROA) | -5.55% |
| Return on Invested Capital (ROIC) | -5.81% |
| Return on Capital Employed (ROCE) | -7.99% |
| Weighted Average Cost of Capital (WACC) | 5.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.23 |
| Inventory Turnover | 3.04 |
Taxes
| Income Tax | -8.31M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.70% in the last 52 weeks. The beta is 0.15, so TPEX:6733's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | -0.70% |
| 50-Day Moving Average | 32.85 |
| 200-Day Moving Average | 37.08 |
| Relative Strength Index (RSI) | 29.11 |
| Average Volume (20 Days) | 238,047 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6733 had revenue of TWD 229.81 million and -67.11 million in losses. Loss per share was -0.54.
| Revenue | 229.81M |
| Gross Profit | 163.46M |
| Operating Income | -89.63M |
| Pretax Income | -84.87M |
| Net Income | -67.11M |
| EBITDA | -44.07M |
| EBIT | -89.63M |
| Loss Per Share | -0.54 |
Balance Sheet
The company has 862.30 million in cash and 5.71 million in debt, with a net cash position of 856.59 million or 6.89 per share.
| Cash & Cash Equivalents | 862.30M |
| Total Debt | 5.71M |
| Net Cash | 856.59M |
| Net Cash Per Share | 6.89 |
| Equity (Book Value) | 1.10B |
| Book Value Per Share | 8.75 |
| Working Capital | 953.87M |
Cash Flow
In the last 12 months, operating cash flow was -44.76 million and capital expenditures -1.87 million, giving a free cash flow of -46.62 million.
| Operating Cash Flow | -44.76M |
| Capital Expenditures | -1.87M |
| Depreciation & Amortization | 45.56M |
| Net Borrowing | -3.71M |
| Free Cash Flow | -46.62M |
| FCF Per Share | -0.37 |
Margins
Gross margin is 71.13%, with operating and profit margins of -39.00% and -29.20%.
| Gross Margin | 71.13% |
| Operating Margin | -39.00% |
| Pretax Margin | -36.93% |
| Profit Margin | -29.20% |
| EBITDA Margin | -19.18% |
| EBIT Margin | -39.00% |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6733 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.80% |
| Shareholder Yield | -0.80% |
| Earnings Yield | -1.91% |
| FCF Yield | -1.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |